Prefilled syringes are devices that are used to store medicines and are sold to patients for the administration of drugs for specific a treatment. They provide single dose administration of drugs and can be used for emergency treatment.The global prefilled syringe for arthritis treatment market is primarily driven due to a rise in the number of cases of arthritis worldwide. According to a study by the Aaarhus University, Denmark, the approximate manufacturing cost of one prefilled syringe is estimated to be around US$ 9 to US$10. Manufacturers can make a significant profit (more than 20%) when they sell prefilled syringes to end-users. Other advantages of these syringes include less overfill of drugs and lower risk of medication errors.
Request Brochure of Prefilled Syringe for Arthritis Treatment Market Report
However, the growth of the global prefilled syringe for arthritis treatment market is restrained by the risk of contamination of disease and stringent regulatory landscape and intellectual property rights laws. Nevertheless, mergers and acquisitions among key players, increase in R&D investment by major companies, and technological progress are estimated to provide the global prefilled syringe for arthritis treatment market an opportunity for expansion during the forecast period.
Major players acting in the global prefilled syringe for arthritis treatment market are AbbVie GK, Sanofi and Regeneron Pharmaceuticals, Inc, Bristol-Myers Squibb Company, UCB Group of Companies, Amgen Inc., Janssen Biotech, Inc, Roche, Eli Lilly and Company, and others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.